Recap: Theravance Biopharma Q4 Earnings
Recap: Theravance Biopharma Q4 Earnings
Theravance Biopharma (NASDAQ:TBPH) reported its Q4 earnings results on Monday, February 26, 2024 at 04:05 PM.
Theravance Biopharma（纳斯达克股票代码：TBPH）于2024年2月26日星期一下午4点05分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Theravance Biopharma missed estimated earnings by -13.0%, reporting an EPS of $-0.17 versus an estimate of $-0.15.
Theravance Biopharma报告的每股收益为-0.17美元，未达到预期的-13.0％，而预期的收益为-0.15美元。
Revenue was up $2.92 million from the same period last year.
收入比去年同期增长了292万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.04 which was followed by a 5.0% increase in the share price the next day.
上个季度，该公司的每股收益高出0.04美元，随后第二天股价上涨了5.0％。
Here's a look at Theravance Biopharma's past performance:
以下是Theravance Biopharma过去的表现：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.16 | -0.26 | -0.17 |
| EPS Actual | -0.17 | -0.13 | -0.24 | -0.21 |
| Revenue Estimate | 15.00M | 15.24M | 13.84M | 15.73M |
| Revenue Actual | 15.69M | 13.75M | 10.42M | 14.65M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.21 | -0.16 | -0.26 | -0.17 |
| 实际每股收益 | -0.17 | -0.13 | -0.24 | -0.21 |
| 收入估算 | 15.00M | 15.24 亿 | 13.84 亿 | 15.73 亿 |
| 实际收入 | 15.69 亿 | 13.75 亿 | 10.42 亿 | 14.65 亿 |
To track all earnings releases for Theravance Biopharma visit their earnings calendar here.
要追踪Theravance Biopharma发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。